Substituted imidazoles as bombesin receptor subtype-3 modulators
申请人:Dobbelaar Peter H.
公开号:US20100204236A1
公开(公告)日:2010-08-12
Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.